Cisplatin treatment increases stemness through upregulation of hypoxia‐inducible factors by interleukin‐6 in non‐small cell lung cancer
Fuquan Zhang(Nanjing Brain Hospital), Yuhchyau Chen(University of Rochester)
Cited by 87
Related Papers
M2 macrophage-derived exosomal long non-coding RNA AGAP2-AS1 enhances radiotherapy immunity in lung cancer by reducing microRNA-296 and elevating NOTCH2
|Cell Death and Disease|2021|106
Radiation alters PD-L1/NKG2D ligand levels in lung cancer cells and leads to immune escape from NK cell cytotoxicity via IL-6-MEK/Erk signaling pathway
|Oncotarget|2017|73
A FASN-TGF-β1-FASN regulatory loop contributes to high EMT/metastatic potential of cisplatin-resistant non-small cell lung cancer
|Oncotarget|2016|62
Combined effects of XAF1 and TRAIL on the apoptosis of lung adenocarcinoma cells
|Experimental and Therapeutic Medicine|2019|8